ALBERTO BAROJA MAZO

Villalba-Lopez F, Garcia-Bernal D, Mateo SV, Vidal-Correoso D, Jover-Aguilar M, Alconchel F, Martinez-Alarcon L, Lopez-Lopez V, Rios-Zambudio A, Cascales P, Pons JA, Ramirez P, Pelegrin P, Baroja-Mazo A. Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation. Biomed Pharmacother. 2023 Sep 18;167:115529. doi: 10.1016/j.biopha.2023.115529. Online ahead of print. PubMed PMID: 37729732.

AÑO: 2023; IF: 7.5

37729732

Martinez-Banaclocha H, Garcia-Palenciano C, Martinez-Alarcon L, Amores-Iniesta J, Martin-Sanchez F, Ercole GA, Gonzalez-Lisorge A, Fernandez-Pacheco J, Martinez-Gil P, Padilla-Rodriguez J, Baroja-Mazo A, Pelegrin P, Martinez-Garcia JJ. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients. Front Immunol. 2023 Nov 29;14:1297249. doi: 10.3389/fimmu.2023.1297249. eCollection 2023. PubMed PMID: 38094297; PubMed Central PMCID: PMC10716420.

AÑO: 2023; IF: 7.3

38094297

Lucas-Ruiz F, Mateo SV, Jover-Aguilar M, Alconchel F, Martinez-Alarcon L, de Torre-Minguela C, Vidal-Correoso D, Villalba-Lopez F, Lopez-Lopez V, Rios-Zambudio A, Pons JA, Ramirez P, Pelegrin P, Baroja-Mazo A. Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation. EBioMedicine. 2023 Jan;87:104419. doi: 10.1016/j.ebiom.2022.104419. Epub 2022 Dec 19. PubMed PMID: 36543018; PubMed Central PMCID: PMC9794897.

AÑO: 2023; IF: 11.1

36543018

Lopez-Lopez V, Miura K, Kuemmerli C, Capel A, Eshmuminov D, Ferreras D, Baroja-Mazo A, Cascales-Campos P, Jimenez-Mascunan MI, Pons JA, Castellon MI, Sanchez-Bueno F, Robles-Campos R, Ramirez P. Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis. Cancers (Basel). 2023 Apr 2;15(7):2122. doi: 10.3390/cancers15072122. PubMed PMID: 37046783; PubMed Central PMCID: PMC10093460.

AÑO: 2023; IF: 5.2

37046783

Baroja-Mazo A, Penin-Franch A, Lucas-Ruiz F, de Torre-Minguela C, Alarcon-Vila C, Hernandez-Caselles T, Pelegrin P. P2X7 receptor activation impairs antitumour activity of natural killer cells. Br J Pharmacol. 2023 Jan;180(1):111-128. doi: 10.1111/bph.15951. Epub 2022 Oct 3. PubMed PMID: 36098250.

AÑO: 2023; IF: 7.3

36098250